Rachna Seth1, Rashmi Ranjan Das2, Kirti Puri3, Prashant Singh3. 1. Additional Professor, Department of Pediatrics, All India Institute of Medical Sciences (AIIMS) , New Delhi, India . 2. Assistant Professor, Department of Pediatrics, All India Institute of Medical Sciences (AIIMS) , Bhubaneswar, India . 3. Intern, Department of Pediatrics, All India Institute of Medical Sciences (AIIMS) , New Delhi, India .
Abstract
INTRODUCTION: Optimal treatment strategy in children with advance stage Hodgkin Lymphoma (HL) still remains controversial. AIM: To evaluate the clinical profile and the efficacy of chemotherapy (CT) as a treatment modality in paediatric HL. MATERIAL AND METHODS: Retrospective case record evaluation of paediatric HL cases over 5 years (October 2005 to October 2010) period. RESULTS: Thirty five cases (31 boys) with a median age of eight years were studied. 24 cases were <10-year-old, and 23 had late stage disease (stage III to IV). B-symptoms were present in 60%, bulky mediastinal disease in 25.7%, and spleen involvement in 60% cases. None had bone marrow involvement. Most common histological type was nodular sclerosis (28.6%). Most cases received ABVD/COPP or ABVD regimen. Two cases needed BEACOPP due to progressive disease, and 4 needed low-dose involved field radiotherapy (RT). At a mean (SD) extended event-free follow-up of 42.7(±17.1) months, four cases relapsed (one was lost to follow-up, and three were treated with chemotherapy and low-dose involved field RT). None died due to the disease. CONCLUSION: Present study found systemic CT alone to be an effective therapy in childhood Hodgkin lymphoma. However, a small sample in present study limits the generalisability of these findings. The findings needs to be replicated in larger population, preferably randomized clinical trials, before any firm conclusion can be made.
INTRODUCTION: Optimal treatment strategy in children with advance stage Hodgkin Lymphoma (HL) still remains controversial. AIM: To evaluate the clinical profile and the efficacy of chemotherapy (CT) as a treatment modality in paediatric HL. MATERIAL AND METHODS: Retrospective case record evaluation of paediatric HL cases over 5 years (October 2005 to October 2010) period. RESULTS: Thirty five cases (31 boys) with a median age of eight years were studied. 24 cases were <10-year-old, and 23 had late stage disease (stage III to IV). B-symptoms were present in 60%, bulky mediastinal disease in 25.7%, and spleen involvement in 60% cases. None had bone marrow involvement. Most common histological type was nodular sclerosis (28.6%). Most cases received ABVD/COPP or ABVD regimen. Two cases needed BEACOPP due to progressive disease, and 4 needed low-dose involved field radiotherapy (RT). At a mean (SD) extended event-free follow-up of 42.7(±17.1) months, four cases relapsed (one was lost to follow-up, and three were treated with chemotherapy and low-dose involved field RT). None died due to the disease. CONCLUSION: Present study found systemic CT alone to be an effective therapy in childhood Hodgkin lymphoma. However, a small sample in present study limits the generalisability of these findings. The findings needs to be replicated in larger population, preferably randomized clinical trials, before any firm conclusion can be made.
Authors: R J Hutchinson; C J Fryer; P C Davis; J Nachman; M D Krailo; R T O'Brien; R D Collins; T Whalen; D Reardon; M E Trigg; G S Gilchrist Journal: J Clin Oncol Date: 1998-03 Impact factor: 44.544
Authors: V Vecchi; S Pileri; R Burnelli; N Bontempi; A Comelli; A M Testi; M Carli; G Sotti; D Rosati; M T Di Tullio Journal: Cancer Date: 1993-09-15 Impact factor: 6.860
Authors: James B Nachman; Richard Sposto; Philip Herzog; Gerald S Gilchrist; Suzanne L Wolden; John Thomson; Marshall E Kadin; Paul Pattengale; P Charlton Davis; Raymond J Hutchinson; Keith White Journal: J Clin Oncol Date: 2002-09-15 Impact factor: 44.544
Authors: S Laskar; T Gupta; S Vimal; M A Muckaden; T K Saikia; S K Pai; K N Naresh; K A Dinshaw Journal: J Clin Oncol Date: 2003-12-02 Impact factor: 44.544
Authors: E Mauricio Castellanos; José Carlos Barrantes; L Fulgencio Báez; Yessica Gamboa; Armando Peña; Soad Alabi; Miguel Bonilla; Huaping Wang; Monika L Metzger; Pedro A de Alarcón Journal: Pediatr Blood Cancer Date: 2013-12-18 Impact factor: 3.167
Authors: R García; J M Hernández; M D Caballero; M González; J Galende; M C del Cañizo; L Vázquez; J F San Miguel Journal: Br J Cancer Date: 1993-12 Impact factor: 7.640